TABLE 3.
Active factor | FC | CE | TG | PL | FC+PL/protein | CE+TG/protein | FC+PL/CE+TG |
µg/µg protein | |||||||
None | 0.29 ± 0.01 | 0.72 ± 0.02 | 0.15 ± 0.01 | 0.84 ± 0.01 | 1.13 ± 0.03 | 0.87 ± 0.02 | 1.29 ± 0.04 |
CETP | 0.30 ± 0.01 | 0.65 ± 0.01 | 0.41 ± 0.01 a | 0.82 ± 0.03 | 1.12 ± 0.03 | 1.06 ± 0.02 a | 1.06 ± 0.03 b |
LCAT | 0.19 ± 0.01 a | 0.74 ± 0.02 | 0.16 ± 0.01 | 0.74 ± 0.02 b | 0.93 ± 0.02 b | 0.91 ± 0.02 | 1.03 ± 0.02 b |
CETP, LCAT | 0.20 ± 0.01 a | 0.71 ± 0.01 | 0.37 ± 0.01 a | 0.70 ± 0.01 a | 0.90 ± 0.02 a | 1.07 ± 0.02 a | 0.84 ± 0.02 a |
Plasma was incubated (37°C) for 16 h in the presence or absence of 1 mM paraoxon to inhibit LCAT and/or TP2 (46 µg/ml plasma) to inhibit CETP activity. LDL was isolated by sequential ultracentrifugation and chemically characterized as described in the Methods. Based on protein, LDL recovery was 98–111%. Values are the mean ± SD of duplicate determinations. Results are representative of 3 similar experiments.
P < 0.01 or
P < 0.05 versus control (CETP and LCAT inactive). FC, free cholesterol; CE, cholesteryl ester; TG, triglyceride; PL, phospholipid.